Merck announced this week that it has reached an agreement to buy privately held biopharmaceutical company Tilos Therapeutics for as much as $773 million. Tilos, which develops therapeutics for the treatment of cancer, fibrosis and autoimmune diseases, was founded by Boehringer Ingelheim Venture Fund and Partners Innovation Fund, based on discoveries by the laboratory of … Continue reading “Merck to Buy Tilos Therapeutics for up to $773 Million”
